A double-blind, placebo-controlled study of naltrexone in pyromania.

Trial Profile

A double-blind, placebo-controlled study of naltrexone in pyromania.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 13 Dec 2011

At a glance

  • Drugs Naltrexone (Primary)
  • Indications Firesetting behaviour
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Apr 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 12 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Aug 2010 as reported by ClinicalTrials.gov.
    • 07 Aug 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top